Commentary: Paracetamol-Induced Glutathione Consumption: Is There a Link With Severe COVID-19 Illness?

Verd, SergioVerd, Mateo2024-09-182024-09-182021-01-26Verd S, Verd M. Commentary: Paracetamol-Induced Glutathione Consumption: Is There a Link With Severe COVID-19 Illness? [editorial]. Front Pharmacol. 2021 Jan 26;11:625295.1663-9812http://hdl.handle.net/20.500.13003/9109https://hdl.handle.net/20.500.12105/23201enghttp://creativecommons.org/licenses/by/4.0/Metabolic syndromeObesityDown syndromeOxidative stressHyperthyroidismGlutathioneCommentary: Paracetamol-Induced Glutathione Consumption: Is There a Link With Severe COVID-19 Illness?editorialAttribution 4.0 International335747611162529510.3389/fphar.2020.625295Frontiers in Pharmacologyopen access2-s2.0-85101030519615977200001L634131245